Our final poster presentation is by Kris Hage - P604, who found that ongoing #HCV-related risk behavior post treatment is present among MSM with HIV, especially among MSM treated with DAAs. This highlights the need for ongoing HCV testing and behavioral interventions #CROI2023

My last canal lunch walk in Amsterdam. Will miss my amazing colleagues from GGD Amsterdam Infectious Disease Research and Burnet Institute ! Off to a new adventure in Boston at CAUSALab in a few weeks! 😁

⚠️Last chance!⚠️ Registration for CAUSALab's Summer Courses closes THIS Monday, June 12. 4⃣exciting courses to choose from led by leading #causalinference experts! Come learn at Harvard T.H. Chan School of Public Health with students from around the world. Info & register 👇causalab.sph.harvard.edu/courses/

Such a great course (advanced confounding adjustment)! 😀 and the teachers, wow. So clear! Helped consolidate some of my causal knowledge. Next week more learning at the target trial emulation course.

Important review in Open Forum Infectious Diseases led by Michael Traeger Burnet Institute on #HCV prevalence and incidence among gay and bisexual men using #PrEP ; key finding is lower #HCV incidence where #PrEP and DAA treatment have been implemented at scale academic.oup.com/ofid/advance-a…

Our meta-analysis of #HCV in #PrEP users now available open access in Open Forum Infectious Diseases. We found lower HCV incidence in contexts where HCV #DAAs have been implemented at-scale - indicative of HCV treatment as prevention among gay and bisexual men.

My type of research ☺️

A great opportunity to get feedback on ongoing or planned research!

Great read! 👇🏾👇🏾

Pleased to share paper from my PhD on #HCV reinfection among gay and bisexual men with HIV across Australia published in Liver International showing a decline in reinfection incidence onlinelibrary.wiley.com/doi/full/10.11… It is beyond time all countries globally removed ALL barriers to #HCV treatment!

Interested in #HCV elimination, and in particular the role of reinfection? read more about it in this paper! Very happy to have been able to contribute to this work with such amazing colleagues 🤓

Congrats to CAUSALab's Dr Daniela van Santen for being awarded #CROI2024 New Investigator Scholarship! Daniela is presenting her work on risk of Hepatocellular carcinoma in people With HIV/HCV coinfection 3/4/24. Learn more : croiconference.org/about/ #causalinference #hivresearch

Happy to continue my work leveraging causal inference methods for #HCV research in people with #HIV ! 😊

Applications are OPEN for CAUSALab Clinics! Free consulting open to Boston-based, junior clinical investigators. Our fellows will provide guidance pertaining to #studydesign, data analysis and results for works in progress. Learn more & apply: causalab.sph.harvard.edu/causalab-clini…